TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
Clinical trial NCT04413617 · COMPLETED
Trial details
- NCT number
- NCT04413617
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2022-02-07
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.